mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for PRLR
Gene summary
Basic gene Info.Gene symbolPRLR
Gene nameprolactin receptor
SynonymsHPRL|MFAB|hPRLrI
CytomapUCSC genome browser: 5p13.2
Type of geneprotein-coding
RefGenesNM_000949.6,
NM_001204314.2,NM_001204315.1,NM_001204316.1,NM_001204317.1,
NM_001204318.1,NR_037910.1,
DescriptionhPRL receptorsecreted prolactin binding protein
Modification date20141207
dbXrefs MIM : 176761
HGNC : HGNC
Ensembl : ENSG00000113494
HPRD : 01457
Vega : OTTHUMG00000090789
ProteinUniProt: P16471
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_PRLR
BioGPS: 5618
PathwayNCI Pathway Interaction Database: PRLR
KEGG: PRLR
REACTOME: PRLR
Pathway Commons: PRLR
ContextiHOP: PRLR
ligand binding site mutation search in PubMed: PRLR
UCL Cancer Institute: PRLR
Assigned class in mutLBSgeneDBA: This gene has a literature evidence and it belongs to targetable_mutLBSgenes.
References showing study about ligand binding site mutation for PRLR.1. "Zhang C, Cherifi I, Nygaard M, Haxholm GW, Bogorad RL, Bernadet M, England P, Broutin I, Kragelund BB, Guidotti JE, Goffin V. Residue 146 regulates prolactin receptor folding, basal activity and ligand-responsiveness: potential implications in breast tumorigenesis. Mol Cell Endocrinol. 2015 Feb 5;401:173-88. doi: 10.1016/j.mce.2014.12.006. Epub 2014 Dec 15." 25524456

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID
GO:0007171activation of transmembrane receptor protein tyrosine kinase activity10585417


Top
Ligand binding site mutations for PRLR
Lollipop-style diagram of mutations at LBS in amino-acid sequence.
We represented ligand binding site mutations only. (You can see big image via clicking.)
 
: non-synonymous mutation on LBS, Circle size denotes number of samples.

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
H65E67KBRCA1
H212,Y214G213RHNSC1
I100Y99SSKCM1
H65H65YSKCM1
R37P39SSKCM1
R37S38ASTAD1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for PRLR
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
R37P39S-1.2134411
R37S38A-0.92818101
Y214G213R-0.86833123
H212G213R-0.86833123
I100Y99S-0.66572854
H65H65Y-0.61571628
H65E67K-0.51593725
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for PRLR from PDB

Top
Differential gene expression and gene-gene network for PRLR
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of PRLR and the right PPI network was created from samples without mutations in the LBS of PRLR. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for PRLR
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type
umls:C0007097Carcinoma3Biomarker
umls:C0024667Mammary Neoplasms, Animal2Biomarker
umls:C0020514Hyperprolactinemia1Biomarker, GeneticVariation
umls:C0004352Autistic Disorder1Biomarker, GeneticVariation
umls:C0000786Abortion, Spontaneous1Biomarker
umls:C0014175Endometriosis1Biomarker
umls:C0024668Mammary Neoplasms, Experimental1Biomarker

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for PRLR
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.

Gene-centered drug-gene interaction network
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure
Approved|investigationalDB00052Somatropin recombinantBiotech
Approved|illicitDB01185FluoxymesteroneSmall molecule

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of PRLR go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS


Top
Conservation information for LBS of PRLR
Multiple alignments for P16471 in multiple species
LBSAA sequence# speciesSpecies
C36PEIHKCRSPDK2Mus musculus, Rattus norvegicus
C36PEIFKCRSPNK1Homo sapiens
C36PTIIKCRSPEK1Gallus gallus
C36PKLVKCRSPGK1Bos taurus
D211TRCKPD-HGYW2Mus musculus, Rattus norvegicus
D211VRCKPD-HGYW1Homo sapiens
D211IHCKPDHHGSW1Gallus gallus
D211IRCKPD-HGYW1Bos taurus
H212CKPD-HGYWSR2Mus musculus, Rattus norvegicus
H212CKPD-HGYWSA1Homo sapiens
H212CKPDHHGSWSE1Gallus gallus
H212CKPD-HGYWSE1Bos taurus
H65YSLTYSKEGEK2Mus musculus, Rattus norvegicus
H65YSLTYHREGET1Homo sapiens
H65YTLLYSKEGEE1Gallus gallus
H65YTLTYHKEGET1Bos taurus
I100IWKIYIITVNA2Mus musculus, Rattus norvegicus
I100MWRTYIMMVNA1Homo sapiens
I100FWTIYNITVRA1Gallus gallus
I100IWKMYVITVNA1Bos taurus
K35KPEIHKCRSPD2Mus musculus, Rattus norvegicus
K35KPEIFKCRSPN1Homo sapiens
K35KPTIIKCRSPE1Gallus gallus
K35KPKLVKCRSPG1Bos taurus
M102KIYIITVNATN2Mus musculus, Rattus norvegicus
M102RTYIMMVNATN1Homo sapiens
M102TIYNITVRATN1Gallus gallus
M102KMYVITVNAIN1Bos taurus
R37EIHKCRSPDKE2Mus musculus, Rattus norvegicus
R37EIFKCRSPNKE1Homo sapiens
R37TIIKCRSPEKE1Gallus gallus
R37KLVKCRSPGKE1Bos taurus
T63TNYSLTYSKEG2Mus musculus, Rattus norvegicus
T63TNYSLTYHREG1Homo sapiens
T63TNYTLLYSKEG1Gallus gallus
T63TNYTLTYHKEG1Bos taurus
W215D-HGYWSAWSP1Homo sapiens
W215DHHGSWSEWSS1Gallus gallus
W215D-HGYWSRWGQ1Mus musculus
W215D-HGYWSRWSQ1Rattus norvegicus
W215D-HGYWSEWSP1Bos taurus
W47ETFTCWWRPGT1Homo sapiens
W47ETFTCWWKPGL1Gallus gallus
W47ETFTCWWNPGS1Mus musculus
W47ETFTCWWNPGT1Rattus norvegicus
W47ETFTCWWEPGA1Bos taurus
Y214PD-HGYWSAWS1Homo sapiens
Y214PDHHGSWSEWS1Gallus gallus
Y214PD-HGYWSRWG1Mus musculus
Y214PD-HGYWSRWS1Rattus norvegicus
Y214PD-HGYWSEWS1Bos taurus
Y64NYSLTYSKEGE2Mus musculus, Rattus norvegicus
Y64NYSLTYHREGE1Homo sapiens
Y64NYTLLYSKEGE1Gallus gallus
Y64NYTLTYHKEGE1Bos taurus


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas